Abstract
The proteolytic 18O labeling method determines the relative ratios of individual proteins between two samples. This technique utilizes a protease and water (H216O and H218O) to produce labeled peptides; peptides in one sample incorporate 16O by labeling in H216O, and the other sample incorporates 18O by labeling in H218O. Both samples are mixed in a 1:1 ratio and subjected to mass spectrometric analysis to identify and quantify the proteins from which the peptides originated. Technical issues in sample preparation and data processing prevented this method from becoming widely accepted in the field of quantitative proteomics, however these problems have been resolved and the technique is now rapidly gaining popularity. This review focuses on the recent technological developments that have improved the reliability and practicality of proteolytic 18O labeling, including improved peptide labeling techniques, techniques to prevent proteasecatalyzed 18O to 16O back exchange reaction, mass spectrometry platforms suitable for this technique, computational tools for the calculation of 16O/18O-peptide ratios, and a new strategy that allows to compare a large number of samples.
Keywords: 18O labeling, isotope labeling, mass spectrometry, proteomics, quantitative proteomics, protein quantification, Electrophoresis, SILAC, LC-MS/MS, Proteolytic Enzymes, Hydrolysis, Chromatography, Glycoslation
Current Proteomics
Title: Recent Technological Developments in Proteolytic 18O Labeling
Volume: 8 Issue: 1
Author(s): Dagmar Hajkova, K. C. Sekhar Rao and Masaru Miyagi
Affiliation:
Keywords: 18O labeling, isotope labeling, mass spectrometry, proteomics, quantitative proteomics, protein quantification, Electrophoresis, SILAC, LC-MS/MS, Proteolytic Enzymes, Hydrolysis, Chromatography, Glycoslation
Abstract: The proteolytic 18O labeling method determines the relative ratios of individual proteins between two samples. This technique utilizes a protease and water (H216O and H218O) to produce labeled peptides; peptides in one sample incorporate 16O by labeling in H216O, and the other sample incorporates 18O by labeling in H218O. Both samples are mixed in a 1:1 ratio and subjected to mass spectrometric analysis to identify and quantify the proteins from which the peptides originated. Technical issues in sample preparation and data processing prevented this method from becoming widely accepted in the field of quantitative proteomics, however these problems have been resolved and the technique is now rapidly gaining popularity. This review focuses on the recent technological developments that have improved the reliability and practicality of proteolytic 18O labeling, including improved peptide labeling techniques, techniques to prevent proteasecatalyzed 18O to 16O back exchange reaction, mass spectrometry platforms suitable for this technique, computational tools for the calculation of 16O/18O-peptide ratios, and a new strategy that allows to compare a large number of samples.
Export Options
About this article
Cite this article as:
Hajkova Dagmar, C. Sekhar Rao K. and Miyagi Masaru, Recent Technological Developments in Proteolytic 18O Labeling, Current Proteomics 2011; 8 (1) . https://dx.doi.org/10.2174/157016411794697372
DOI https://dx.doi.org/10.2174/157016411794697372 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diffusion Tensor Imaging of Brain Metastases in Patients with Breast Cancer According to Molecular Subtypes
Current Medical Imaging PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging
Current Protein & Peptide Science Pistachio Green Hull Extract Induces Apoptosis through Multiple Signaling Pathways by Causing Oxidative Stress on Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Wnt Signaling and Cell-Matrix Adhesion
Current Molecular Medicine Meet Our Associate Editor:
Current Molecular Medicine The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry MicroRNAs in Colon and Rectal Cancer - Novel Biomarkers from Diagnosis to Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Vitamin D Deficiency: Universal Risk Factor for Multifactorial Diseases?
Current Drug Targets KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
Recent Patents on DNA & Gene Sequences Ruthenium as an Effective Nitric Oxide Scavenger
Current Topics in Medicinal Chemistry Future Prospects for Old Chemotherapeutic Drugs in the Target-Specific Era; Pharmaceutics, Combinations, Co-Drugs and Prodrugs with Melphalan as an Example
Letters in Drug Design & Discovery Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
Current Medicinal Chemistry Vascular Endothelial Growth Factor and Angiopoietins in Neurovascular Regeneration and Protection Following Stroke
Current Neurovascular Research Optimization of Performance Variables of Exemestane Nanosuspension Using Box-Behnken Design to Improve Dissolution and Oral Bioavailability
Current Drug Delivery Five Common Functional Polymorphisms in microRNAs (rs2910164, rs2292832, rs11614913, rs3746444, rs895819) and the Susceptibility to Breast Cancer: Evidence from 8361 Cancer Cases and 8504 Controls
Current Pharmaceutical Design Editorial (Thematic Issue: Treatment of Cancer in the Elderly)
Anti-Cancer Agents in Medicinal Chemistry Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy
Current Pharmaceutical Design Resveratrol and Cancer Treatment: Is Hormesis a Yet Unsolved Matter?
Current Pharmaceutical Design Enhanced Anticancer Activity and Apoptosis Effect of Bioactive Compound Quercetin Extracted from <i>Ocimum sanctum</i> Leaves
Current Nanomedicine The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa
Letters in Drug Design & Discovery